• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RAYNER INTRAOCULAR LENSES LIMITED RAYONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RAYNER INTRAOCULAR LENSES LIMITED RAYONE Back to Search Results
Model Number NOT AVAILABLE
Device Problem Optical Problem (3001)
Patient Problem Visual Impairment (2138)
Event Type  malfunction  
Manufacturer Narrative
The reference (b)(4) has been allocated to this case by rayner.The event description provided states that the patient's post-operative outcome was not as expected and that examination identified that the capsular bag was bulging posteriorly.The patient underwent an additional surgical procedure one week post-operatively to resolve the bulging capsular bag and to improve their refractive outcome.The description of the lens bulging posteriorly suggests that residual ovd had been left behind the iol (capsular bag distension syndrome - cbds, capsular block).Cbds occurs when fluid accumulates between the iol and the posterior capsule, leading to a distention of the posterior capsule with anterior displacement of the iol.The trapped fluid develops a turbid consistency which leads to a decreased visual acuity for the patient and can be associated with either a myopic (most common) or hyperopic shift.Published literature and rayner's own risk analysis identifies the most common cause of cbds to be residual ovd in the eye.The "use of rayone" section of the ifu "fig 7" includes the instruction ".Following implantation, irrigate/aspirate to eliminate any ovd residues from the eye, especially behind the iol".Additionally, "deviation from target refraction" is listed in the "adverse events" section of the ifu.Rayner is following up with its distributor to obtain additional information to facilitate further investigation of the event including but not limited to: product lot number, patient medical history, ovd information and an overview of the surgical procedure.
 
Event Description
On (b)(6) 2023, rayner received notification from its distributor in the netherlands of an event that occurred following implantation of a rayone iol (model unknown at the time of this report).The event description provided states that the patient's post-operative outcome was not as expected and that examination identified that the capsular bag was bulging posteriorly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAYONE
Type of Device
RAYONE
Manufacturer (Section D)
RAYNER INTRAOCULAR LENSES LIMITED
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 8AQ
UK  BN14 8AQ
Manufacturer (Section G)
RAYNER INTRAOCULAR LENSES LIMITED
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 8AQ
UK   BN14 8AQ
Manufacturer Contact
jodie neal
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 -8AQ
UK   BN14 8AQ
MDR Report Key16500808
MDR Text Key310856076
Report Number3012304651-2023-00028
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodeNL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNOT AVAILABLE
Device Catalogue NumberNOT AVAILABLE
Device Lot NumberNOT AVAILABLE
Date Manufacturer Received02/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-